Related Experiment Videos
Current treatment options in neuropathic pain
Kathleen Hempenstall1, Andrew S C Rice
1Department of Anaesthetics, The Hillingdon Hospital, Uxbridge, Middlesex, UK.
Current Opinion in Investigational Drugs (London, England : 2000)
|June 11, 2002
Summary
Neuropathic pain, caused by nervous system damage, is difficult to treat. This review examines randomized controlled trials for effective drug treatments for this persistent pain condition.
Area of Science:
- Neurology
- Pharmacology
- Pain Medicine
Background:
- Neuropathic pain arises from nervous system damage, leading to persistent and severe pain.
- This pain is often resistant to standard pain relief medications.
- Management typically involves a multidisciplinary approach, including pharmacotherapy.
Purpose of the Study:
- To review evidence from randomized controlled trials (RCTs).
- To assess the efficacy of current drug treatments for neuropathic pain.
Main Methods:
- Systematic review of randomized controlled trials.
- Analysis of pharmacotherapy options for neuropathic pain.
Main Results:
- Current drug treatments for neuropathic pain show variable efficacy.
- No single medication is universally effective.
- Antidepressants and antiepileptics have been used empirically.
Conclusions:
- Effective pharmacotherapy for neuropathic pain remains a challenge.
- Further research is needed to identify optimal drug treatments.
- Multitherapy pain clinics offer comprehensive management strategies.